The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.
The company said it is consolidating its workforce drug testing operations at its Lenexa, Kansas, lab to meet growing demand for oral fluid and hair testing.
The company is seeking FDA de novo classification for the screening test, which is a capillary, blood-based lateral flow ...
The company looks to tackle the Alzheimer's market by supplying global diagnostics firms with the antibodies needed for their tests in the space.
Beckman Coulter will use the antibody as part of a p-tau 217 in vitro diagnostic on its DxI 9000 Immunoassay Analyzer to aid in the diagnosis of the disease.
The five-year grant will support the development of a palm-sized instrument and test strips that could provide results within ...
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
In addition, Canadian retail pharmacy chain Shoppers Drug Mart has joined the company as a commercial partner.
Last week, readers were most interested in a story about NowDx raising $22.5 million and its plans to commercialize its at-home diagnostic tests.
Labcorp will manage daily operations of NCH's inpatient lab operations and will begin later this summer to serve as the primary lab for NCH's physician network.
The three other Medicare Administrative Contractors that participate in the MolDx program aligned their coverage with Palmetto's.
Renalytix received clearance for the test from the US Food and Drug Administration about a year ago and is now preparing for commercialization in other markets.